Multi-Center Project: BETTER CARE - HF (Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,136
- 试验地点
- 4
- 主要终点
- Number of Patients with a Prescription for Mineralocorticoid Antagonists (MRA)
研究概览
简要总结
This study will test an automated, electronic health record (EHR-)embedded alert to improve prescribing of guideline-directed medical therapy for patients with heart failure and reduced ejection fraction (HFrEF). The investigators have previously tested and implemented this alert at NYU Langone Health (NYULH), and will now test and implement this alert across three other health systems.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient with an encounter visit at participating cardiology practice during the study period
- •Patient with EF of less than or equal to 40% on most recent echocardiogram at the time of visit
- •Patient ages 18-90
排除标准
- •Pregnancy
- •Ventricular assist device
- •Cardiac amyloid
- •Medication-specific exclusion for MRA: most recent systolic blood pressure less than 105 mm Hg, most recent potassium < 5.1, any potassium > 5.5, most recent glomerular filtration rate < 30 (using MDRD equation), or a documented MRA allergy.
研究组 & 干预措施
Standard of Care
Participants who are randomized to the control group (i.e., not displaying the automated EHR-embedded alert).
Intervention
Participants who are randomized to receive the intervention (i.e., displaying the automated EHR-embedded alert).
干预措施: EHR-Emedded Alert (Other)
结局指标
主要结局
Number of Patients with a Prescription for Mineralocorticoid Antagonists (MRA)
时间窗: Up to Day 30
Measured at the prescription encounter level using patient EHR data.
次要结局
- Number of Patients who are Hospitalized(Up to Month 36)
- Number of Patients who are Hospitalized for Heart Failure (HF)(Up to Month 36)
- Number of Patients with a Prescription for Beta-Blocker (BB)(Up to Day 30)
- Number of Patients with a Prescription for ACE-I/ARB/ARNI(Up to Month 36)
- Number of Patients with a Prescription for Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i)(Up to Month 36)
- Number of Patients with Hyperkalemia(Up to Month 36)